iGMDRD79
Canonical SMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
InChI: InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1
InChI Key: SDUQYLNIPVEERB-QPPQHZFASA-N
Drug Class:
Anti-Infective AgentsAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntiviral AgentsCarbohydratesCytidineDeoxyribonucleosidesEnzyme InhibitorsGlycosidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunologic FactorsImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acids, Nucleotides, and NucleosidesNucleoside Metabolic InhibitorNucleosidesP-glycoprotein/ABCB1 SubstratesPyrimidine AnaloguesPyrimidine NucleosidesPyrimidinesRadiation-Sensitizing AgentsRibonucleosidesRibonucleotide Reductases, antagonists & inhibitorsToxic ActionsDrug Synonyms:
Gemcitabine (USAN/INN)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Gemcitabine
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |